Algernon NeuroScience Announces Successful Completion of Highest Planned Single Dose in DMT Phase 1 Trial; Accelerates Plans for Phase 2 Stroke and TBI Studies
05 juin 2023 07h00 HE
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage...
Neuronic and Santa Clara University partner to develop next-gen neurotech for photobiomodulation guided by real-time brain activity
11 mai 2023 12h00 HE
|
Neuronic Devices Operations GmbH
Integrating photobiomodulation with neurofeedback will revolutionize treatment of brain disorders SANTA CLARA, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Neuronic, a multi-national company focused...
Algernon NeuroScience Announces U.S. SEC Qualification of Regulation A+ Tier II Offering to Raise up to USD $10M
03 avr. 2023 07h00 HE
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, April 03, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage...
Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
21 mars 2023 16h05 HE
|
Telesis Bio
-- Record revenue of $9.5M in 4QFY22; Increase of 208% over 4QFY21 -- BioXp® Revenue increased by 158% to $3.4M, in 4QFY22 over 4QFY21 SAN DIEGO, March 21, 2023 (GLOBE NEWSWIRE) -- Telesis Bio...
Social Life Network Announces Name Change on OTC Markets to Decentral Life, Inc.
03 févr. 2023 13h11 HE
|
Decentral Life, Inc
GREENWOOD VILLAGE, CO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Decentral Life, Inc. (OTC: WDLF), a Technology Business Incubator (TBI), previously named Social Life Network, Inc., is pleased to announce...
Social Life Announces Record Growth in 2022, Topping 300% Increase in Annual Sales
06 janv. 2023 11h35 HE
|
Social Life Network, Inc.
significantly increased its annual sales by 318% year-over-year from 2021 while holding operating expenses in line with 2021 has significantly increased operating income for 2022 LOS ANGELES, CA,...
Aviv Clinics and America’s Mighty Warriors Partner to Provide Life-Changing Treatments to Veterans Suffering from Concussion, Traumatic Brain Injury
11 nov. 2022 09h12 HE
|
Aviv Clinics
ORLANDO, Fla., Nov. 11, 2022 (GLOBE NEWSWIRE) -- Aviv Clinics, the global leader in the research and treatment of brain conditions, today announces a pledge of $1 million in in-kind treatments to...
Endonovo Therapeutics Releases Comparative Analysis Demonstrating
28 juil. 2022 09h08 HE
|
Endonovo Therapeutics, Inc.
More Effective SofPulse® Results Compared With Bioelectronics RecoveryRx® Los Angeles, CA, July 28, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB:ENDV) today released superior...
Constant Therapy Announces Publication of Study Demonstrating Improved Outcomes for Post-Stroke Patients Using Its Digital Speech, Language, and Cognitive Therapy
20 juil. 2022 10h46 HE
|
Constant Therapy Health
LEXINGTON, Mass., July 20, 2022 (GLOBE NEWSWIRE) -- Constant Therapy Health, a brain health digital therapeutics company, announced today the publication of a dosage study in the Journal of Medical...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages TrueBlue, Inc. Investors to Inquire About Securities Class Action Investigation – TBI
05 juil. 2022 12h43 HE
|
The Rosen Law Firm PA
NEW YORK, July 05, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of TrueBlue,...